Transgene SA
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
11.69-7.15-5.15
Price/Sales ratio
1.908.762.78
Earnings per Share (EPS)
€0.26€-0.42€-0.59

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.41-2.08-5.84-5.5120.48-6.03-7.47-11.56-5.02-6.17N/AN/A
Price/Sales ratio
105.6065.9262.8584.74123.1419.3646.2423.1552.77116.39N/A19.36
Price/Book Value ratio
3.663.633.176.334.471.962.743.444.358.82N/A1.96
Price/Cash Flow ratio
-4.84-2.13-4.39-5.02-5.79-5.74-4.79-7.24-8.12-3.97N/A-5.79
Price/Free Cash Flow ratio
-4.62-2.06-4.38-4.96-5.51-5.33-4.65-7.09-7.55-3.68N/A-5.51
Price/Earnings Growth ratio
0.900.430.09-0.41-0.160.020.48N/A-0.100.18N/A-0.16
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-510.44%-79.93%13.17%-304.95%-1948.08%-371.81%-817.34%-229.06%-929.04%-2398.98%N/A-1948.08%
Operating Profit Margin
-1884.81%-2444.16%-966.06%-1336.01%551.91%-382.65%-804.86%-235.41%-956.62%-2537.75%N/AN/A
Pretax Profit Margin
-1916.98%-2587.64%-1030.81%-1537.58%601.19%-282.68%-578.02%-195.49%-1049.39%-2430.57%N/AN/A
Net Profit Margin
-1950.04%-3165.46%-1074.46%-1537.58%601.19%-321.10%-618.91%-200.18%-1049.58%-1885.81%N/AN/A
Effective Tax Rate
-12.03%-38.15%-2.06%9.58%0.24%-13.59%-7.07%-2.39%-0.01%22.41%N/AN/A
Return on Assets
-34.44%-45.97%-20.50%-31.99%7.39%-18.49%-21.59%-19.64%-49.38%-49.37%N/AN/A
Return On Equity
-67.58%-174.68%-54.20%-114.89%21.86%-32.51%-36.71%-29.76%-86.70%-143.01%N/AN/A
Return on Capital Employed
-39.30%-48.29%-21.99%-33.38%8.27%-26.28%-33.40%-26.96%-55.73%-85.42%N/AN/A
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
3.621.863.703.461.502.532.254.262.381.79N/A2.53
Cash ratio
0.160.120.240.090.090.070.380.400.341.56N/A0.07
Days of Sales Outstanding
225.743.53KN/A445.85214.35N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
27.59161.1739.5911.595.9128.140.000.00181.27N/AN/A28.14
Operating Cycle
253.333.69K39.59457.45220.2628.140.000.00181.27N/AN/A28.14
Days of Payables Outstanding
199.21902.94807.04123.1563.9582.4767.6185.3879.0256.06N/A82.47
Cash Conversion Cycle
54.122.79K-767.44334.29156.30-54.33-67.61-85.38102.24-56.06N/AN/A
Debt Ratios
Debt Ratio
0.180.260.290.340.290.090.000.00N/AN/AN/A0.09
Debt Equity Ratio
0.351.000.791.240.870.160.000.00N/AN/AN/A0.16
Long-term Debt to Capitalization
0.190.410.370.470.370.130.00N/AN/AN/AN/A0.13
Total Debt to Capitalization
0.260.500.440.550.460.140.000.00N/AN/AN/A0.14
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-2.12-1.68-0.91-1.01-0.88-2.06-103.76-280.20N/AN/AN/A-0.88
Company Equity Multiplier
1.963.792.643.592.951.751.701.511.752.89N/A1.75
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-21.78-30.82-14.31-16.85-21.25-3.36-9.64-3.19-6.49-29.28N/A-21.25
Free Cash Flow / Operating Cash Flow Ratio
1.041.031.001.011.041.071.021.021.071.07N/A1.07
Cash Flow Coverage Ratio
-2.12-1.68-0.91-1.01-0.88-2.06-103.76-280.20N/AN/AN/A-0.88
Short Term Coverage Ratio
-6.87-5.47-3.70-3.85-2.85-34.85-176.33-280.20N/AN/AN/A-2.85
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A